Atlas Trials

Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells in Adults With Retinitis Pigmentosa

Clinical trial NCT03073733 · COMPLETED

Trial details

NCT number
NCT03073733
Sponsor
jCyte, Inc
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Retinitis Pigmentosa
Start date
2017-03-01
Primary completion
2020-11-13
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.